279
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Clinical Characteristics of Intermediate Uveitis in Chinese Patients

, MRCP, FRCS, , MB ChB, , MRCS, , FRCS, , FRCS, FRCOphth, , FRCS & , MD, FRCS, FRCOphth show all
Pages 71-76 | Received 16 Jun 2012, Accepted 30 Sep 2012, Published online: 16 Jan 2013

REFERENCES

  • Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140(3):509–516.
  • Chang JH, Wakefield D. Uveitis: a global perspective. Ocul Immunol Inflamm. 2002;10(4):263–279.
  • Yang P, Zhang Z, Zhou H, et al. Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res. 2005;30(11):943–948.
  • Wakabayashi T, Morimura Y, Miyamoto Y, et al. Changing patterns of intraocular inflammatory disease in Japan. Ocul Immunol Inflamm. 2003;11(4):277–286.
  • Khairallah M, Yahia SB, Ladjimi A, et al. Pattern of uveitis in a referral centre in Tunisia, North Africa. Eye. 2007;21(1):33–39.
  • Oruc S, Kaplan AD, Galen M, et al. Uveitis referral pattern in a midwest university eye center. Ocul Immunol Inflamm. 2003;11(4):287–298.
  • Lau KK, Wong WW, Sheng B, et al. The clinical course of multiple sclerosis patients in Hong Kong. J Neurol Sci. 2008;268(1–2):78–82.
  • Pugliatti M, Sotgiu S, Rosati G. The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg. 2002;104(3):182–191.
  • Bloch-Michel E, Nussenblatt RB. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol. 1987;103(2):234–235.
  • Nussenblatt RB, Palestine AG, Chan CC, et al. Standardization of vitreal inflammation activity in intermediate and posterior uveitis. Ophthalmology. 1985;92:467–471.
  • Lai WW, Pulido JS. Intermediate uveitis. Ophthalmol Clin North Am. 2002;15(3):309–317.
  • Taylor SR, Lightman SL, Sugar EA, et al. The impact of macular edema on visual function in intermediate, posterior and panuveits. Ocul Immunol Inflamm. 2012;20(3):171–181.
  • Donaldson MJ, Pulido JS, Herman DC, et al. Pars planitis: a 20-year study of incidence, clinical features, and outcomes. Am J Ophthalmol. 2007;144(6):812–817.
  • Prieto JF, Dios E, Gutierrez JM, et al. Pars planitis: epidemiology, treatment, and association with multiple sclerosis. Ocul Immunol Inflamm. 2001;9(2):93–102.
  • de Boer J, Berendschot TT, van der Does P, et al. Long-term follow-up of intermediate uveitis in children. Am J Ophthalmol. 2006;141(4):616–621.
  • Romero R, Peralta J, Sendagorta E, et al. Pars planitis in children: epidemiologic, clinical, and therapeutic characteristics. J Pediatr Ophthalmol Strabismus. 2007;44(5):288–293.
  • Guest S, Funkhouser E, Lightman S. Pars planitis: a comparison of childhood onset and adult onset disease. Clin Exp Ophthalmol. 2001;29(2):81–84.
  • Babu BM, Rathinam SR. Intermediate uveitis. Indian J Ophthalmol. 2010;58(1):21–27.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.